Skip to content

Charles River Laboratories CRL Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$27.4M+84.3%
Sotera Health logo
Sotera HealthSHC
-$10.86M-6.8%
Revvity logo
RevvityRVTY
-$74.69M-115%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
-$1.3M+94.4%
IQVIA logo
IQVIAIQV
-$74.75M-92.9%
TEC
Bio-TechneTECH
-$22.1M-168%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's change in accrued liabilities?
Charles River Laboratories (CRL) reported change in accrued liabilities of -$83.76M in Q1 2026.
How has Charles River Laboratories's change in accrued liabilities changed year-over-year?
Charles River Laboratories's change in accrued liabilities decreased by 648.8% year-over-year, from $15.26M to -$83.76M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.